BlackRock’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

BlackRock’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-440,600	Closed	-$32.7M	–	5946
2022 Q2	$32.7M	Buy	+440,600	New	+$33.1M	﹤0.01%	2784
2022 Q1	–	Sell	-1,747,800	Closed	-$196M	–	5917
2021 Q4	$196M	Buy	+1,747,800	New	+$211M	0.01%	1748

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock's XBI Position: Q1 2026 in Review

BlackRock reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 36% in Q1 2026, selling an estimated $10.5M and leaving 148,817 shares worth $19M. The position accounts for ﹤0.01% of the portfolio, ranked #3117.

BlackRock first reported a position in XBI in Q3 2019 and has held it in 26 quarters since. The position peaked at $55.2M in Q4 2022. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

BlackRock held 148,817 shares of State Street SPDR S&P Biotech ETF worth $19M as of Q1 2026.
BlackRock sold 83,975 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $10.5M.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3117 holding.
BlackRock first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and has held it in 26 quarters since.
BlackRock's State Street SPDR S&P Biotech ETF position peaked at $55.2M in Q4 2022.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.